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Abstract: Aim: A comparative morphometric study of heart condition on various organizational levels (organ, tissue, and 
cellular one) in each clinical stage of neuroleptic cardiomyopathy. 
Methods and results: Morphometric methods of research were used which meet modern requirements of the evidence-
based medicine. For analysis of data from organometry of heart an own original method was used. For this analysis the 
outer volume of heart without atria (V) was determined and two relative parameters (both in percent) were calculated: 1) 
Cv - coefficient of volume, this coefficient shows a part of the total volume of heart (without atria), and this part falls on 
the volume of cavities of ventricles; and 2) Cl - coefficient of the left ventricle, this coefficient shows the volume size of 
the left ventricle with respect to the total volume of both ventricles. In addition, two other parameters were calculated 
which use a gravimetric characteristic of the heart (m): mass-volume ratio (MVR) and index of density of myocardium 
(IDM). 
It was found that on the organ level the process of cardiac remodeling ends during the latent stage of the disease. 
Progression of myocardial dysfunction is connected with changes of myocardium microstructure. 
The studied micromorphometric parameters describe the condition of three structural components of myocardium 
(vasculature, intercellular matrix, and parenchyma). Such parameters as zone of pericapillary diffusion (ZPD), Kernogan 
index (KI), SPR, RIE were calculated. Karyometry and cytometry of cardiomyocytes (CMCs) were performed, the specific 
volumes of hypertrophied CMCs (SVHC), of atrophied ones (SVAC), and – by the method of polarization microscopy – 
the specific volume of dystrophic ones (SVDC) were determined.  
In the latent stage the microcirculatory disorders prevail. In the full-scale stage the damages of intercellular matrix come 
to the forefront. For the terminal stage the atrophic and dystrophic-degenerative changes of cardiomyocytes are 
characteristic. 
Conclusion: In the course of morphogenesis of a neuroleptic cardiomyopathy a certain staging of clinical manifestations 
of the disease is observed; this staging corresponds to an observed cardiac remodeling on the organ level and to an 
observed chain of interconnected pathologic shifts in all microstructures of myocardium. 
Keywords: Neuroleptic cardiomyopathy, Morphogenesis, Remodeling of heart, Structural damages of myocardium, 
Morphometric research. 
INTRODUCTION 
Neuroleptic cardiomyopathy (NCMP) is one of 
serious complications of psychotropic therapy, this 
complication is caused by a side cardiotoxic effect of 
antipsychotic drugs [1-4]. To number of the last treat as 
classical preparations (chlorpromazine, haloperidol, 
levomepromazine, loxapine, perphenazine, pimozide, 
thioridazine, trifluoperazine, etc.), and atypical 
antipsychotics (aripiprazole, clozapine, olanzapine, 
quetiapine, risperidone, ziprasidone, etc.). 
NCMP passes through 3 stages in its development: 
1) a latent one, clinically fully compensated one, 2) a 
full-scale one, when cardiac disorders are clearly 
detected, but without evident signs of congestive heart 
failure (CHF), and 3) a terminal one, when the clinical 
picture of CHF comes to the foreground [9, 11-13]. 
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It is well-known that all changes of function of some 
or other organs, tissues and cells are initially caused by 
their structural damages which are a physical substrate 
of pathophysiological shifts [9]. It follows from this 
thesis that various cardiac disorders in patients with 
NCMP, which are characteristic for a certain stage of 
the disease, are based on morphologic changes of 
heart on various organizational levels (organ, tissue, 
and cellular one), and these changes reflect the 
morphogenesis of this pathology.  
At the same time according to the modern doctrine 
of morphology as a science, a merely descriptive 
method of research is not enough for a correct and 
objective characteristic of pathologic changes being 
observed; it is strongly necessary to use objective 
criteria of functional morphology [10, 11] and to be 
guided by the principle of unity of pathology on various 
research levels; this principle was postulated by G. G. 
Avtandilov [10] in the past. 
Therefore it seems actual important to research a 
morphofunctional condition of heart in patients with 
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NCMP by use of morphometric research methods 
which meet modern requirements of the evidence-
based medicine [12, 13]. The specified methods allow 
to receive objective results and to draw reliable 
conclusions, because final values of the parameters, 
which are studied, have the quantitative form and can 
sufficiently easily be analyzed statistically [10, 11]. 
But until now, a deep comparative morphological 
study of heart condition on each of the before-named 
levels and in each clinical stage of NCMP has not been 
performed. 
Therefore the aim of the present study is a 
comparative morphometric study of heart condition on 
various organizational levels (organ, tissue, and cellular 
one) in each clinical stage of neuroleptic 
cardiomyopathy. 
MATERIAL AND METHODS 
It is known that a quantitative morphologic 
characteristic of changes of each organ in the case of 
its any pathology must start from a definite "reference 
point" which is defined by the concept of a "norm" [14]. 
Therefore at the research beginning the results of 
autopsy protocols of 100 persons (50 men and 50 
women) in the age from 18 to 82 years were analyzed 
who died from non-cardiac causes and who did not 
have any accompanying cardiac pathology and this fact 
was verified by autopsy (group I). The cardiac 
parameters, which were received in this group, are 
taken as a relative norm (RN). 
Then autopsy protocols of 80 dead persons in the 
age from 16 to 77 years (60 men and 20 women) were 
studied, in which the NCMP was revealed by section. 
In 36 of these patients the disease was in the latent 
stage (group II), in 15 patients it was in the full-scale 
stage (group III), and in 29 patients it was in the 
terminal stage (group IV). 
The following parameters were measured on the 
macroscopic level: heart mass (m), linear dimensions, 
perimeter of venous valve openings, and thickness of a 
wall of ventricles. For analysis of the received data we 
used an original method that we had developed for 
such studies [15]. 
For this analysis the outer volume of heart without 
atria (V) was determined and two relative parameters 
(both in percent) were calculated: 1) Cv - coefficient of 
volume, this coefficient shows a part of the total volume 
of heart (without atria), and this part falls on the volume 
of cavities of ventricles; and 2) Cl - coefficient of the left 
ventricle, this coefficient shows the volume size of the 
left ventricle with respect to the total volume of both 
ventricles. In addition, two other parameters were 
calculated which use a gravimetric characteristic of the 
heart (m): mass-volume ratio (MVR) and index of 
density of myocardium (IDM). 
A growth of MVR is evidence of a hypertrophy of 
myocardium, and its diminution is an indication for 
dilatation of cavities of heart ventricles. IDM clearly 
shows a strongly expressed correlation with such 
objective parameters of microstructure of cardiac 
muscle as stromal-parenchymatous ratio (SPR) and 
rate of interstitial edema (RIE) [15], which quantitatively 
describe a condition of its intercellular matrix. 
Myocardium was histomorphometrically examined 
in 80 cases (group 1 - 22, group 2 - 24, group 3 - 13, 
group 4 - 21).  
Myocardium slices from various departments of the 
left ventricle were filled in paraffin, cuts were painted by 
hematoxylin and eoziny. Respective objects were 
studied in 10 different fields of microscope, with 
necessary magnifications with the help of an ocular 
micrometer, the point count method was also used [10, 
11, 16]. Such parameters as zone of pericapillary 
diffusion (ZPD), Kernogan index (KI), SPR, RIE were 
calculated. Karyometry and cytometry of 
cardiomyocytes (CMCs) were performed, the specific 
volumes of hypertrophied CMCs (SVHC), of atrophied 
ones (SVAC), and – by the method of polarization 
microscopy – the specific volume of dystrophic ones 
(SVDC) were determined. The above-named 
parameters describe a condition of three structural 
components of myocardium: of microvasculature (ZPD 
and KI), stroma (SPR and RIE), and parenchyma 
(SVHC, SVAC and SVDC). 
The received results were statistically processed by 
means of the computer program "Statistica 6.0" and by 
the nonparametric Mann- Whitney’s U-criterion with 
significance level of distinctions 95% and more 
(p≤0.05). 
RESULTS 
The results of research which has been conducted 
on the organ level are presented in the Table 1. As 
follows from its analysis, all macroscopic cardiac 
parameters in the case of NCMP statistically 
significantly differ from RN. At the same time, no 
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significant differences of m, V and MVR were found in 
various clinical stages of NCMP. 
The dynamics of values Cv has the same character. 
At the same time, the values Cl differ from RN only in 
the terminal stage of NCMP, and to a significantly 
lesser degree than Cv. 
Changes of IDM are the most important ones. The 
values of this parameter grow already in the latent 
stage of NCMP (group II) and steadily progress later 
on. 
A comparison of parameters of myocardium 
microstructure in the groups, which were studied and 
monitored, among themselves reveals definite 
regularities (Table 2). First of all, a considerable and 
statistically significant difference of all parameters, 
which were calculated in the case of NCMP, from the 
same parameters in the case of RN is observed. On 
the other hand, the parameters, which describe  
Conditions of some or other morphologic structures 
of myocardium in various stages of NCMP, behave 
differently. For example, parameters, which describe 
the microvasculature, do not practically change 
throughout the whole disease. A certain observed 
growth of their values statistically remains on the level 
of a tendency. 
On the contrary, parameters of intercellular matrix of 
myocardium in the full-scale and terminal stages of 
NCMP (groups III and IV) statistically significantly differ 
not only from RN, but also from these parameters in 
the latent stage too. 
The dynamics of changes of CMCs is distinctive 
too. For example, such parameter as SVHC is the 
highest in the group II and it subsequently declines and 
reaches the level of RN in the group IV. As to the 
values of SVAC and SVDC, they steadily grow in the 
course of NCMP development and considerably differ 
in each subsequent group of monitoring from these 
values in the preceding ones. 
DISCUSSION 
According to analysis of detected changes of heart, 
which take place on various levels of its organization in 
different clinical stages of NCMP, we think that the 
disease has the following morphogenesis. 
In the case of NCMP the cardiomegaly develops 
already during the latent stage of the disease and does 
not distinctly progress subsequently. This is proved by 
the absence of significant differences of m, V and MVR 
in different clinical stages of NCMP. 
At the same time, changes of Cv and Cl tell about 
an uniform dilatation of both heart ventricles with some 
predominance of the left one, only in the late phases of 
NCMP morphogenesis (terminal stage). On the 
contrary, an initially progressive growth of IDM tells 
about the developing damages of myocardium 
microstructure, in particular, about changes of its 
intercellular matrix. 
Table 1: Macroscopic Characteristic of Heart during NCMP Morphogenesis 
Gr. m V Кv Кl МVR IDM 
I 
300 
±3,0 
131,6 
±6,1 
32,1 
±0,5 
39,1 
±0,6 
2,28 
±0,04 
4,42 
±0,08 
II 
355 
±9,0 
1  
р=0,041 
163,5±5,4 
1 р=0,039 
41,4 
±1,0 
1  
р=0,033 
40,2 
±0,7 
2,17 
±0,04 
6,06 
±0,06 
1  
р=0,031 
III 
358 
±12,0 
1 р=0,034 
165,8±6,8 
1 р=0,031 
42,6 
±1,7 
1 р=0,031 
40,3 
±0,8 
2,16 
±0,06 
1 р=0,036 
6,24 
±0,06 
1 2 р=0,029 р=0,040  
IV 
361 
±10,0 
1 р=0,034 
167,5±5,1 
1 р=0,029 
43,2 
±1,5 
1 р=0,030 
40,6 
±0,7 
1 р=0,039 
2,15 
±0,05 
1 р=0,036 
6,36 
±0,05 
1 2 3 р=0,026 р=0,037 
р=0,043 
Note: 1 – statistically significant distinctions with gr. I 
2 – statistically significant distinctions with gr. II  
3 – statistically significant distinctions with gr. III  
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Thus, the received data are evidence of the fact that 
the process of the cardiac remodeling, which takes 
place in the course of NCMP development on the 
organ level, ends when the disease passes to the full-
scale stage. Further progression of a myocardial 
dysfunction leads to the development of CHF and is 
determined by the growing changes of microstructure 
of cardiac muscle and its respective components: of 
microvasculature, stroma (intercellular matrix) and 
parenchyma (CMCs). In other words, appearance of 
clinical manifestations of NCMP is accompanied by 
transition of cardiac remodeling to the deeper (tissue 
and cellular) organizational levels. 
This thesis is confirmed and convincingly proved by 
results of morphometric research of myocardium 
microstructure changes in various stages of NCMP 
morphogenesis, which correspond to the clinical stages 
of the disease course. 
In the latent stage of NCMP (group II), first of all, 
disorders of microcirculation are detected, and this is 
reflected by growth of the values of ZPD and KI. 
Vascular changes cause considerable pathologic shifts 
in intercellular matrix of myocardium which manifest 
themselves through an increase of an interstitial edema 
and through development of myofibrosis (growing 
values of RIE and SPR correspondingly). The result of 
the described pathologic processes is damages of 
CMCs, these damages initially have a compensatory-
adaptive character in the form of a cellular hypertrophy 
[17, 18]. Atrophic and dystrophic-degenerative 
parenchymatous changes are observed to a lesser 
degree. 
In the full-scale stage (group III) the evidence of 
pathologic processes in intercellular matrix of cardiac 
muscle considerably grows - an interstitial edema, that 
becomes chronic, as well myofibrosis and small-focal 
(substitutive) cardio sclerosis. Parameters, which 
describe the condition of microvasculature, do not 
statistically differ from the ones in the latent stage of 
NCMP (group II). 
Amount of hypertrophied CMCs considerably 
decreases, although it remains significantly higher than 
RN. At the same time, dystrophic and atrophic 
processes, which take place in CMCs, statistically 
reliably intensify, and these processes are reflected by 
statistically significant growth of such parameters as 
SVDC and SVAC. 
Thus, in the full-scale stage of NCMP the vascular 
disorders do not play the deciding part in the process of 
disease morphogenesis on the tissue and cellular 
levels any more, and the main significance is gained by 
stromal changes which are initially caused exactly by a 
pathology of microcirculation and which lead to a 
considerable imbalance of CMCs' fractions. 
As the result of the above-said, a further growth of 
pathologic shifts in myocardium parenchyma take place 
and the disease passes to the terminal stage (group 
IV). 
Table 2: Morphometric Indicators of a Myocardium during NCMP Morphogenesis 
Microvasculature Intercellular Matrix Cardiomyocytes 
Gr. 
ZPD KI SPR RIE SVHC SVAC SVDC 
I 111,3±17,9 1,22±0,10 8,1±5,0 7,1±4,6 10,2±5,0 4,8±3,6 2,2±2,6 
II 
189,3±51,8 
1  
р=0,041 
1,54±0,21 
1  
р=0,039 
39,2±6,2 
1  
р=0,025 
36,4±6,1 
1  
р=0,019 
37,3±6,1 
1  
р=0,016 
23,6±5,4 
1  
р=0,019 
12,8±4,2 
1  
р=0,014 
III 
282,5±82,2 
1  
р=0,034 
1,61±0,18 
1  
р=0,037 
70,7±5,2 
1 2  
р=0,021 
р=0,041 
75,8±5,8 
1 2  
р=0,012 
р=0,042 
20,1±6,6 
1 2  
р=0,026  
р=0,040 
36,6±6,1 
1 2  
р=0,016  
р=0,034 
27,7±5,1 
1 2  
р=0,012  
р=0,033 
IV 
289,0±79,1 
1  
р=0,033 
1,70±0,17 
1  
р=0,035 
73,7±4,7 
1 2  
р=0,017 
р=0,039 
78,8±4,6 
1 2  
р=0,01  
р=0,039 
16,5±6,4 
2  
р=0,029 
46,1±5,4 
1 2 3  
р=0,012  
р=0,033  
р=0,044 
37,4±4,6 
1 2 3  
р=0,011  
р=0,036  
р=0,041 
Note: 1 – statistically significant distinctions with gr. I 
2 – statistically significant distinctions with gr. II  
3 – statistically significant distinctions with gr. III  
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In this period the fraction of hypertrophied CMCs 
continues to decrease and statistically returns to the 
level of RN. Atrophic and dystrophic-degenerative 
changes of CMCs distinctly increase and come to the 
forefront (statistically significant growth of SVAC and 
SVDC as compared with the group III). These 
processes are considered as an indisputable indicator 
of a progressive myocardial dysfunction [17, 18]. 
Values of other parameters of myocardium 
microstructure fluctuate on the level of a tendency; their 
differences from a preceding group of research are 
statistically insignificant. 
These data are evidence that in the terminal stage 
of NCMP the atrophy and dystrophy of parenchyma 
have the main significance, which are an outcome of 
pathologic processes having earlier taken place in 
microvasculature and in extracellular matrix of 
myocardium. The above-named parenchymatous 
changes form a physical basis of a final myocardial 
dysfunction which clinically manifests itself through the 
development of a fatal CHF. 
Thus, a chain of pathologic processes, which 
develop in heart on the tissue and cellular 
organizational levels in the course of NCMP 
morphogenesis, is a distinctive quasi relay-race of 
structural changes of myocardium. In the initial phase 
(latent stage), microcirculatory disorders are leaders. 
Then (in the full-scale stage) the damages of 
intercellular matrix in the form of the interstitial edema 
and cardio sclerosis join in and come to the forefront. In 
the final phase of the disease (terminal stage), the 
atrophic and dystrophic-degenerative changes of 
CMCs prevail. 
CONCLUSION 
The conducted research has proved that in the 
course of NCMP morphogenesis not only a certain 
staging of clinical manifestations of the disease is 
observed, but also a chain of interconnected and 
interdependent pathologic shifts in all myocardium 
structures, which corresponds to this staging - shifts in 
microvasculature, stroma and parenchyma. 
In addition, in the latent stage of the disease the 
microcirculatory disorders have the deciding 
significance in the progression of the pathology; 
subsequently, they gradually lead to stromal changes 
and through them to damages of CMCs. 
In the full-scale stage of NCMP the vascular 
processes go to the sidelines, and the pathologic shifts 
in intercellular matrix gain the leading role. In addition, 
at the same time the damages of parenchyma increase 
and their compensatory-adaptive character 
(hypertrophy of CMCs) is replaced by predominance of 
atrophic and dystrophic-degenerative cellular changes. 
In the terminal stage the key pathogenetic factors 
are atrophy and dystrophy of myocardium parenchyma. 
They are a physical basis for development of a severe 
CHF and they proceed against the background of 
earlier changes of microvasculature and stroma of 
cardiac muscle. 
The above-named micro structural pathologic shifts 
in cardiac muscle correspond to cardiac remodeling on 
the organ level. In the latent stage of the disease, the 
macroscopic cardiac remodeling reflects the 
compensatory-adaptive processes which are directed 
towards preservation of the pumping function of heart. 
The full-scale stage of NCMP is characterized by 
termination of remodeling on the organ level, and the 
further progression of myocardial dysfunction, which is 
to the maximum expressed in the terminal stage of the 
disease, takes place because of the above-described 
pathologic changes of myocardium on the tissue and 
cellular organizational levels, what leads to a fatal CHF. 
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